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1. Introduction
HIV/AIDS is  probably the most challenging and pressing health issue of  our time.  Cur‐
rent  estimates  show  that  over  40million  people  are  now  living  with  HIV.  Despite  the
availability of  antiretroviral  therapy,  the provision of  this  treatment continues to pose a
big challenge for  various reasons.  Globally,  of  the 6  million people requiring treatment,
only  8% receive  it  –  with  considerable  geographical  inequity  ie.  High income countries
vs.  low income countries.  Despite  understanding  the  risk  factors  for  HIV infection,  the
incidence  of  new  HIV  cases  has  not  reduced  at  an  acceptable  rate.  An  unprecedented
number of people still have no access to treatment and continue to die from HIV related
problems. This has brought about devastating social and economic consequences at coun‐
try level, family level and at personal level. A considerable number of individuals suffer
from mental  disorders  resulting  from being  HIV infected.  Independently,  mental  disor‐
ders  make  a  substantial  independent  contribution  to  the  burden  of  disease  worldwide.
The recognition of  mental  disorders  as  a  major contributor to the global  burden of  dis‐
ease has led to an increase in the demand for the inclusion of mental health services in
primary health care as  well  as  in  community-based health surveys in order  to  improve
screening, diagnosis and treatment of mental distress. It is estimated that, neuropsychiat‐
ric  conditions account for  up to 15% of  all  disability-adjusted life-years,  and up to 30%
of  those  attributable  to  non-communicable  diseases.  Neuropsychiatric  disorders  also  ac‐
count for 1.2 million deaths every year.  These figures are most likely underestimated as
official  statistics  especially  in  low and middle  income countries  are  scanty  and unrelia‐
ble. In sub-Saharan Africa, it  has been reported that 20–30% of primary health care cen‐
tre  attendees  present  with  depressive  symptoms  as  the  first  or  secondary  reason  for
seeking medical care. A study conducted in Tanzania revealed a 41.6% prevalence of de‐
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pressive symptoms among primary health care patients while a similar study in Uganda
reported  a  20–30% prevalence  of  psychological  disorders  and  depression  among  health
care seekers. These research findings have also shown heightened risk for common men‐
tal disorders among the women i.e. a female to male ratio of 1.5–2.0. Other determinants
have been found to include low socioeconomic position indicated by poor access  to  re‐
sources,  unemployment  and  low  educational  attainment.  It  has  also  been  shown  to  be
higher among those with poor socio-support networks such as the unmarried, widowed
and divorced. Mental disorders interact with many other health conditions,  communica‐
ble  and  non-communicable.  They  commonly  affect  individuals  with  medical  conditions
and  have  been  associated  with  adverse  impacts  on  several  measures  of  morbidity  and
mortality. Depressed patients have been shown to have worse physical,  social and over‐
all  health than other patients.  Of particular interest  to this chapter is  the interaction be‐
tween HIV and mental distress
2. HIV and mental distress
Early stages of HIV epidemic
In the early stages of the HIV epidemic, the individuals who were affected did not know
that their behaviour predisposed them to a potentially fatal disease. The epidemic also
mushroomed at the time of a liberal and tolerant culture and dis-inhibited sexual restraint.
Hence multiple sexual partners spread the epidemic in communities where these behaviours
were more rampant. Intravenous drug use also contributed to the early spread of the epi‐
demic. In the low and middle income countries, factors surrounding poor socio-economic
position (poor education and low income) and inability to negotiate for condom use due to
the disparity between the male and female gender have emerged as stronger predictors.
Several early and recent epidemiologic studies elucidated these risk factors and more con‐
certed effort was placed on public education directed at prevention. Other more recent inno‐
vations directed at rolling-back HIV infection have included massive male circumcision
campaigns, innovation directed at the girl child to reduce early teenage pregnancies and ear‐
ly marriages and the introduction of Highly Active Anti-Retroviral Therapy (HAART). Re‐
cently efforts have been directed at the role mental distress plays in determining acquisition
of HIV infection, initial individual’s reaction and post-infection adaptation. Further poor
mental health has been associated with subsequent development of AIDS.
Mental distress
Mental distress in the context of this book chapter refers to a term used by users of mental
health services as well as some mental health practitioners in describing a wide array of ex‐
periences of a patient's life that commonly manifest as somatic symptoms and held to be out
of the ordinary, distressing, troubling or confusing for the patient, without actually being ill
in the medical sense. Chipimo and Fylkesnes identified some of the common causes of men‐
tal distress in a study conducted among primary health care centers in Zambia. (Table 1)
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Category of factor Frequency Symptoms/comments
Worries about money 51 Concerns about rent, day-to-day living, school fees
Problems of the mind 47 Recurrent headaches, sleeplessness, unhappiness, trouble thinking,
loss of appetite, night mares
Unknown cause of symptoms 32 Most common among informants not acknowledging symptoms as
an illness or as mental distress, suggested witchcraft
Relationship with spouse and
family members
26 Commonest among women, included crying more than usual,
unhappiness, headaches, sleeplessness.
Ill health 24 Sleeplessness, daily life suffering, inability to play useful role in life,
tiredness
Low self-esteem 16 Worthlessness, loss of interest, unhappiness, crying more than usual,
difficulty enjoying daily activities, experience of stigma
Recent life events 6 Bereavement, divorces, newly diagnosed with chronic disease
including HIV. Included symptoms of restlessness, sleeplessness,
trouble thinking, headache, unhappiness
Table 1. Factors associated with Mental Distress as identified by the informants (Chipimo & Fylkesnes, 2011)
The term mental distress is seen by users of mental health services as less stigmatizing as it
fits better with the social model of disability, since everyone experiences mental distress at
one time or the other. The other synonym is psychological distress. The term is also often
preferred as they feel it better captures the uniqueness and personal nature of their experi‐
ences. Mental distress is often thought of as being a concept with a wider scope than the reg‐
ularly used traditional term, mental illness. The later being a specific set of symptoms
medically defined in psychiatry, for example: Mania, schizophrenia, anxiety disorders, de‐
pression etc. Difficult life situations such as: poor social-support structures, bereavement,
stress, poor sleep, drug and alcohol abuse can induce mental distress. These inducers could
be temporary and resolve without further medical intervention. However individuals who
have protracted episodes and endure such symptoms longer are more likely to be diagnosed
with mental illness. This definition is not without controversy and often these terms are
used interchangeably.
Double tragedy
Mental distress has been recognised as a crucial factor to some individual’s ability to modify
their behaviour to prevent HIV infection. With effective treatment options now available,
care for HIV has become more dynamic and has transformed the HIV squeal from terminal
care to chronic care. This further complicates the scenario as mental disorders have further
been recognised as severely complicating treatment. These factors work in tandem with HIV
causing direct damage on the brain, creating turmoil in the lives of the infected and further
exacerbates mental disorders. Further the mental disorders reduce the individual’s ability to
effectively change behaviour thus increasing the risk of infection and morbidity. Published
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literature showing that individuals with pre-existing mental disorders are at increased risk
for contracting HIV/AIDS has been largely indirect. However consistent reports from sever‐
al countries have suggested that individuals with mental disorders have a higher sero-prev‐
alence for HIV/AIDS and that mental distress generally precedes HIV infection. This is valid
given that significant risk of HIV transmission exists within an individual’s network. Fre‐
quencies of 30-60% behavioural risk factors that have been identified among individuals
with mental distress include: high rates of unprotected sexual contact, poor adherence to
condom use and injection-drug abuse. In a study conducted among gay men with depres‐
sive symptoms, use of alcohol and drugs before sex were identified as independent predic‐
tors for sero-conversion. In a systematic review comparing an HIV sero-positive group and
HIV sero-negative control group, the prevalence of depression in the sero-positive group
was two times higher than in the sero-negative (OR 2.0, 95% CI 1.3-3.0).
3. Aetiology of HIV related mental distress
HIV related mental distress can occur in multiple phases in which premorbid psychological
and social adjustment issues play a vital role. Additionally other social factors such as
household income, culture, religion and family circumstances also influence and can alter an
individual’s reaction to a diagnosis of HIV and subsequent adaptation to living with the di‐
agnosis. The same factors have also been shown to influence and pose high risk of being in‐
fected With HIV. Put together all these factors singly or severally affect the clinical
presentation and management of HIV patients. It is as such imperative that these factors are
addressed and assessed in both the Voluntary-Counselling-and-Testing (VCT) and in the
pre-HAART assessment. A self-perpetuating cycle (figure 1) of increasing morbidity ap‐
pears to occur between HIV and mental distress; HIV infection leads to development of
mental distress and/or pre-existing mental distress predispose to HIV infection. In their
study, Chipimo and Fylkesnes (2009) showed that HIV infection has both a direct and indi‐
rect effects on genesis of mental distress.
Direct effect
HIV infection has been known to affect all other organ systems in the human body and is
said to have replaced syphilis as the “great imitator” in the central nervous system (CNS)
and almost any psychiatric or neurological presentation is possible. The CNS is the second
most commonly affected organ in patients with AIDS. HIV can cause direct organic brain
tissue damage thus leading to the development of mental disorders (Psychotic and non-psy‐
chotic). Virtually any mental disorder is possible. Among the most notable are depression
and anxiety, personality disorders and dementia. The mechanisms explaining the develop‐
ment of these mental disorders are largely poorly understood but the presence of HIV-1-
binding sites in the brain (chemokine receptors) allows HIV-1 to infect macrophages and
microglia. It is however thought that it does not affect neurons, although neurons are in‐
jured and die by apoptosis. The pathway to neuronal injury is thought to be through release
of macrophage, microglial and astrocyte toxins alongside the contribution of direct injury on
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the neurons by viral proteins. These toxins overstimulate neurons, resulting in the formation
of free radicals and excitotoxicity, similar to other neurodegenerative diseases.
Figure 1. Self-perpetuating cycle of increasing morbidity: HIV/AIDS and Mental Distress (Chipimo, 2011)
Many HIV related opportunistic infections may involve the brain and lead to mental disor‐
ders. The four most frequent conditions are toxoplasmosis, progressive multifocal leukoen‐
cephalopathy (PML), cryptococcosis and cytomegalovirus infection. Although the incidence
of these infections among patients with AIDS has decreased in the past years as a conse‐
quence of the introduction of highly active antiretroviral therapy (HAART), they remain a
major cause of morbidity and mortality in this patient group. However, highly active antire‐
troviral drugs themselves such as, Zidovudine, Didanosine and Effervirenz have been asso‐
ciated with development of manic episodes
Indirect effect
Chipimo and Fylkesnes (2009) studied the relationship between HIV and mental distress
in a  population with high prevalence of  HIV infection and low awareness  of  own HIV
sero-status.  In  this  study structural  equation modeling (SEM) was used to  establish  the
relationship between HIV infection and mental  distress using maximum likelihood ratio
as  the  method of  estimation.  The  model  indicated that  underlying  factors  such as  resi‐
dence (rural or urban), level of education, marital status and age were inter-correlated as
determinants for mental distress.  Further Mental distress was found to be directly relat‐
ed  to  self-perceived risk  and worry  about  being  HIV infected,  HIVsero-status  and self-
rated  health.  Further  indirect  inter-relationships  were  also  found  between  self-rated
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health,  self-perceived risk and worry about being HIV infected,  and the underlying fac‐
tors,  namely  age,  residence,  socio-economic  position and education.  Therefore  self-rated
health and self-perceived risk and worry about being HIV infected appear to be impor‐
tant mediators between underlying factors and mental  distress.  They are also important
mediators  between HIV status  and mental  distress.  The  results  suggest  that  HIV infec‐
tion  has  a  substantial  effect  on  mental  distress  both  directly  and  indirectly.  This  effect
was  mediated  through  self-perceptions  of  health  status,  found  to  capture  changes  in
health  perceptions  related  to  HIV,  and  self-perceived  risk  and  worry  of  actually  being
HIV infected.
4. Prevalence of HIV related mental distress
Prevalence studies conducted world over have shown that when compared to the gener‐
al population, mental disorders where considerably higher among the HIV infected indi‐
viduals.  However  most  of  these  studies  have  been  conducted  in  the  high  income
countries  were the disease burden is  relatively low and confined to selected groups for
example  Injection  drug  users  and  Homosexuals.  Similar  data  in  sub-Saharan  Africa,
where  the  HIV  epidemic  has  its  worse  impact  is  limited.  Therefore,  given  that  mental
disorders manifest in the majority of HIV infected individuals over the course of the ill‐
ness, a simple assumption would then be that the prevalence reported in published stud‐
ies represent an underestimate of the actual prevalence. A meta-analytic study identified
13 studies  on mental  disorders  and HIV infection in low and middle income countries.
The prevalence of mental disorders varied widely among these studies. Most of the stud‐
ies done in Africa with HIV positive participants have shown differing but high percen‐
tages of mental distress, for example, Orange free state, South Africa 40%, rural Ethiopia
14%  and  Botswana  28%.  In  a  study  done  in  Zambia,  Chipimo  and  Fylkesnes  (2009)
found a 13% prevalence of mental distress within the general population with a 2.0 high‐
er  odds  ratio  among the  HIV infected.  In  Uganda,  Musisi  et.  al.  (2006)  showed a  42%
prevalence of depression among HIV infected individuals while in another study, Musisi
& Kinyanda reported a prevalence of 41% among HIV infected adolenscents.
5. Presentation of HIV related mental distress
Diagnosis of mental disorders in HIV infection is a relatively rarely made diagnosis in sub-
Saharan Africa. Studies have reported that physicians tend to be oblivious to psychological
problems in HIV in the presence of a physical ailment. Further, the clinical presentation of
mental distress in HIV infection presents a diagnostic challenge. This is often because the
clinical Indictors of mental disorders are often masked by the symptoms of HIV infection. It
is also a challenge for health care providers to distinguish between mental distress and grief.
This calls for careful history taking that probes for previous history of mental disorders in
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the patient, suicide attempts, family history of mental illness, poor social support structures
and a history of recent adverse events (deaths in family, physical violence, divorce, stigma).
Symptoms
Several studies have shown that mental distress often presents as somatisation. In a popula‐
tion based survey, Chipimo and Fylkesnes (2009) reported that the most frequently reported
symptoms among the HIV infected were:
1. difficulty enjoying life,
2. feeling that their daily life was suffering,
3. poor sleep
4. low energy levels.
Among patients attending Primary Health Care, the most commonly reported symptoms
observed by Chipimo and Fylkesnes (2010) were:
1. feelings of unhappiness,
2. loss of interest,
3. inability to enjoy daily life,
4. poor sleep
5. frequent headaches
Women reported these symptoms more than men in both studies. Musisi and Akena (2009)
reported similar battery of symptoms and further added that, an otherwise asymptomatic
HIV infected individual presenting with symptoms of fatigue and insomnia should be as‐
sessed for severe depression. These and other more pathognomonic symptoms put together
allow clinicians to make a diagnosis of a full blown psychiatric disorder. The recognised
HIV related psychiatric disorders are:
1. Anxiety disorders and depression
2. Psychotic disorder (Primary or secondary)
3. HIV-related Mania
4. HIV-related Dementia
5. HIV-related Delirium
6. Drug abuse ie. Substance and Alcohol abuse
6. Impact of HIV related mental distress on course and prognosis
There is a general lack of reported/ published follow-up studies on HIV related mental dis‐
tress. However left untreated mental distress has an effect on the cell mediated immunity,
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where it causes impairments in T-cell mediated functions, reduced natural-killer cell counts
and cytotoxicity. Depression in particular, has reproducibly been associated with decreased
numbers and altered functioning of natural killer lymphocytes. It can also lead to an in‐
crease in activated CD8 T lymphocytes and viral load. By so doing mental distress can pre‐
dict the onset and progression of both physical and social disability in HIV infection.
Further, Co-morbid mental distress can delay health seeking hence reducing the likelihood
of diagnosis and so can affect treatment and outcome in HIV infection. They may also ad‐
versely affect adherence to medication and activities to prevent disease and promote health.
7. Management
Mental disorders episodes are known to cluster around specific times in the course of the
illness, such as, the period of diagnosis of HIV, period when the infected individual starts
declining in health or the period in the early stages of HIV dementia. However, an episode
of mental distress can occur at any point in the course of the illness. In the early stages social
support alone can suffice alongside psychotherapy. However, in the later stages anti-depres‐
sants such as Imipramine or Amitriptyline can be used. Selective serotonin re-uptake inhibi‐
tors such as Fluoxetine may also be prescribed.
However the mainstay of management should fall around the time of diagnosis with ade‐
quate pre and post testing counseling surrounding the HIV test. The HIV counseling process
should also be optimized to conditions that allow for higher acceptability of the counseling
process. A Clinical trial study conducted in Zambia showed higher acceptability for Home-
based-Voluntary-Counseling and testing as opposed to facility based counseling. Such inno‐
vative means of facilitating the counseling process will by induction lead to better
acceptance of the HIV sero-status thus preventing subsequent maladjustment disorders.
This has been shown in literature to reduce the risk of suicide at the initial diagnosis. Addi‐
tionally follow-up counseling at every stage in the disease process emphasizing safer sex
should be promoted alongside care giver support. This support should especially be extend‐
ed to the most vulnerable; the women, children, orphans and those of low socio-economic
position in society.
8. Conclusion
Mental disorders are common place in HIV infection and potentiate the course, progression
and prognosis of the HIV disease process. The direct and indirect impact of HIV on the in‐
fected individual has conversely also been associated with mental distress episodes. Mental
disorder and HIV/AIDS also have a lot of socio-demographic factors in common that have
been attributed to each of their development. Therefore, a combination of these two disease
entities leads to devastating morbidity and mortality, especially in the most affected com‐
munities. This thus emphasizes the need for prompt screening, diagnosis and treatment of
mental distress in HIV infection.
HIV Infection8
Author details
Peter J. Chipimo1,2 and Knut Fylkesnes1
1 University of Bergen, Faculty of Medicine, Centre for International Health, Norway
2 University of Zambia, School of Medicine, Department of Public Health, Zambia
References
[1] Bock PJ, Markovitz D. Infection with HIV-2. AIDS. 2001;15(Suppl 5):S35-45.
[2] Chipimo P.J. Fylkesnes K, Mental distress in the general population in Zambia: Im‐
pact of HIV and social factors: BMC Public Health. 2009; 9: 298. http://
www.ncbi.nlm.nih.gov/pmc/articles/PMC2744699/
[3] Chipimo Peter J, Mental health in the era of HIV. Investigating mental distress, its
determinants, conceptual models and the impact of HIV in Zambia. BORA-UiB 2011
http://hdl.handle.net/1956/4882
[4] Chipimo PJ, Fylkesnes K. Comparative validity of screening instruments for Mental
Distress in Zambia. Clinical practice & Epidemiology in Mental Health. 2010;6:4-15.
[5] Chipimo PJ, Tuba M, Fylkesnes K, Conceptual models for Mental Distress among
HIV infected and uninfected: A contribution to clinical practice and research in pri‐
mary health-care centers in Zambia. BMC Health Services Research 2011; 11:7 1-12
[6] Chipimo, Peter Jay: Mental Distress and the Impact of HIV: Data from a Population-
Based Survey in Zambia, Master thesis (2007) http://www.uib.no/cih/en/research/cih-
master-theses
[7] Department of Health and Human Services (Ed). A Pocket Guide to Adult HIV/AIDS
Treament January edition 2005
[8] DeVellis RF. Scale Development: Theory and Application. London: SAGE Publica‐
tions; 2003.
[9] Escobar JI, Waitzkin H, Silver RC, Gara M, Holman A. A bridged somatization: a
study in primary care. Psychosom Med. 1998;60:466-72.
[10] Gottlinger HG. The HIV-1 assembly machine. AIDS. 2001;15(Suppl 5):S13-20.
[11] Jenkins R. Sex differences in minor psychiatric morbidity: a survey of a homogene‐
ous population. Social Science and Medicine. 1985;20(9):887-99.
[12] Kigozi FN, Flisher AJ, Lund C, Funk M, Banda M, Bhana A, et al. Mental health poli‐
cy development and implementation in four African Conutries. Journal of health
psychology. 2007;12(3):505-16.
Human Immunodeficiency Virus Infection and Co-Morbid Mental Distress 9
[13] Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early verses defered anti-retro‐
viral therapy for HIV on survival. N Engl Med. 2009;360(18):1815-26.
[14] Kroenke K, Spitzer RL, Williams JB, et al. Physical symptoms in primary care: Predic‐
tors of psychiatric disorders and functional impairement. Arch Fam Med.
1994;3:774-9.
[15] Kuehner C. Gender diffferences in unipolar depression: an update of epidemiological
findings and possible explanations. Acta Psychiatr Scand. 2003;108:163-74.
[16] Maier W, Gansicke M, Gater R, Rezaki M, Tiemens B, Urzua RF. Gender differences
in the prevalence of depression: A survey in primary care. J Affect Disord.
1999;53:241-52.
[17] Mathers CD, Loncar D. Projections of global mortality and burden of disease from
2002 to 2030. Plos Med. 2006;3(e442).
[18] McCaffery JM, Frasure-Smith N, Dude MP, et al. Common genetic vulnerability to
depressive symptoms and coronary artery disease: a review and development of can‐
didate genes related to inflamation and serotonin. Psychosom Med. 2006;68:187-200.
[19] Murray CJL, Lopez AD, et al. The global burden of disease and injuries series: A
comprehensive assessment of Mortality and disability, Injuries and Risk factors 1990
and projected to 2020. Volume 1: Cambridge, MA; 1996.
[20] Ngoma MC, Prince M, Mann A. Common mental disorders among those attending
primary health clinics and traditional healers in urban Tanzania. Br J Psychiatry.
2003;183:349-55.
[21] Ovuga EBL, Boardman A, Oluka GAO. Traditional healers and mental illness in
Uganda. Psychiatric Bull. 1999;23:276-9.
[22] Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. De‐
clining morbidity and mortality among patients with advanced human immunodefi‐
ciency virus infection. N Engl Med. 1998;338(13):853-60.
[23] Patel V, Abas M, Broadhead J, Todd CH, Reeler AP. Depression in developing coun‐
tries: Lessons from Zimbabwe. BMJ. 2001;322(482).
[24] Rachlis AR, Zarowny DP. Guidelines for anti-retroviral therapy for HIV infection.
Canadian HIV trials Network Antiretroviral Working Group. CMAJ. 1998;158(4):
496-505.
[25] Sax PE, Baden LR. When to start anti-retroviral therapy- ready when you are? N Engl
Med. 2009;360(18):1897-9.
[26] Saz P, Dewey ME. Depression symptoms and mortality in persons aged 65 and over
living in the community: a systematic review of the literature. Int J Geriatric Psychia‐
try. 2001;16:622-30.
HIV Infection10
[27] Strong K, Mather C, Leeder S, Beaglehole R. Preventing Chronic diseases: How many
lives can we save? Lancet. 2005;366:1578-82.
[28] Tatt ID, Barlow KL, Nicoll A. The public health significance of HIV-1 subtypes.
AIDS. 2001;15(Suppl 5):S59-71.
[29] Vieweg WV, Julius DA, Fernandez A, et al. Treatmeant of depression in patients with
coronary heart disease. Am J Med. 2006;119:567-73.
[30] Wilson D, Naidoo S, Bekker L, Cotton M, Maartens G. Handbook of HIV medicine.
Cape Town: Oxford University press; 2002.
[31] Young TN, Arens FJ, Kennedy GE, Laurie JW, Rutherford G. Antiretroviral post-ex‐
posure prophylaxis (PEP) for occupational HIV exposure. Cochrane Database Syst
Rev. 2007;1(CD002835).
Human Immunodeficiency Virus Infection and Co-Morbid Mental Distress 11

